Evidence map›Paper›PMID 34504334›Full record

ArticleNature neuroscience2021

Author Correction: Ventral tegmental area GABAergic inhibition of cholinergic interneurons in the ventral nucleus accumbens shell promotes reward reinforcement.

Ream Al-Hasani, Raajaram Gowrishankar, Gavin P Schmitz, Christian E Pedersen, David J Marcus, Sofia E Shirley, Taylor E Hobbs, Abigail J Elerding, Sophie J Renaud, Miao Jing and 4 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Nature neuroscience, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Ream Al-Hasani *Center for Clinical Pharmacology, University of Health Sciences and Pharmacy and Washington University in St. Louis School of Medicine, St. Louis, MO, USA. al-hasanir@wustl.edu.ORCID http://orcid.org/0000-0002-8781-6234
Raajaram Gowrishankar *Center for the Neurobiology of Addiction, Pain and Emotion, University of Washington, Seattle, WA, USA.
Gavin P Schmitz *Center for Clinical Pharmacology, University of Health Sciences and Pharmacy and Washington University in St. Louis School of Medicine, St. Louis, MO, USA.
Christian E PedersenCenter for the Neurobiology of Addiction, Pain and Emotion, University of Washington, Seattle, WA, USA.
David J MarcusCenter for the Neurobiology of Addiction, Pain and Emotion, University of Washington, Seattle, WA, USA.
Sofia E ShirleyCenter for the Neurobiology of Addiction, Pain and Emotion, University of Washington, Seattle, WA, USA.
Taylor E HobbsCenter for the Neurobiology of Addiction, Pain and Emotion, University of Washington, Seattle, WA, USA.ORCID http://orcid.org/0000-0002-8593-6910
Abigail J ElerdingCenter for the Neurobiology of Addiction, Pain and Emotion, University of Washington, Seattle, WA, USA.
Sophie J RenaudDepartment of Anesthesiology, Washington University in St. Louis, St. Louis, MO, USA.
Miao JingChinese Institute for Brain Research, Beijing, China.
Yulong LiState Key Laboratory of Membrane Biology, Peking University School of Life Sciences, Beijing, China.ORCID http://orcid.org/0000-0002-9166-9919
Veronica A AlvarezLaboratory on Neurobiology of Compulsive Behaviors, Intramural Research Program, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD, USA.ORCID http://orcid.org/0000-0003-2611-8675
Julia C LemosLaboratory on Neurobiology of Compulsive Behaviors, Intramural Research Program, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD, USA.
Michael R BruchasDepartment of Anesthesiology, Washington University in St. Louis, St. Louis, MO, USA. mbruchas@uw.edu.ORCID http://orcid.org/0000-0003-4713-7816

Funding

DISSECTING DYNORPHIN-KAPPA OPIOID MEDIATED REINSTATEMENT OF NICOTINE PREFERENCER37DA033396 · NIDA · WASHINGTON UNIVERSITY · PI Michael R. Bruchas · 2018 to 2026
$3.8M
DEFINING DYNORPHIN-CRF CIRCUITS IN STRESS AND NICOTINE BEHAVIORSR00DA038725 · NIDA · ST. LOUIS COLLEGE OF PHARMACY · PI AL-HASANI, REAM · 2017 to 2019
$747k
CRF actions in the nucleus accumbens in mice with different life historiesR00MH109627 · NIMH · UNIVERSITY OF MINNESOTA · PI LEMOS, JULIA C · 2018 to 2020
$747k
DEFINING DYNORPHIN-CRF CIRCUITS IN STRESS AND NICOTINE BEHAVIORSK99DA038725 · NIDA · WASHINGTON UNIVERSITY · PI AL-HASANI, REAM · 2015 to 2016
$280k
NIDA NIH HHS R00 DA038725NIDA NIH HHS R37 DA033396NIMH NIH HHS R00 MH109627U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (NIDA) K99/R00 DA038725
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID34504334

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.